Allergy Injection: The Anatomy of One SCIT Visit
An allergy injection (singular) is one subcutaneous administration of FDA-licensed allergen extract — meaningful only as a step in a 3-to-5-year SCIT course, not as a standalone treatment. Each dose involves pre-injection screening, verification of vial and dose, subcutaneous injection into the upper outer arm, a mandatory 30-minute observation, and a local-reaction check afterward. Most searches for a single 'allergy injection' are actually looking for a depot steroid — which is not immunotherapy.
5 peer-reviewed sources
A single allergy injection is one visit in subcutaneous immunotherapy (SCIT) — delivered subcutaneously into the upper outer arm, followed by a mandatory 30-minute observation, as part of a 3-to-5-year course of 60-80+ visits.
The essentials
An allergy injection (singular) is a single administration of subcutaneous immunotherapy (SCIT) — defined in the AAAAI/ACAAI/JCAAI Practice Parameter Third Update (Cox L, Nelson H, Lockey R et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1-S55, DOI 10.1016/j.jaci.2010.09.034). The singular framing is a useful lens for understanding the anatomy of one clinical visit, but the injection only produces benefit as one step in a structured dose-escalation course of 24-28 weekly build-up visits followed by maintenance every 2-4 weeks for 3-5 years.
The most common reason a search lands on 'allergy injection' looking for a one-time treatment is the confusion with a depot corticosteroid (Kenalog-40 or Depo-Medrol) given at a primary care office. That injection is anti-inflammatory and symptomatic — not allergen immunotherapy. SCIT, by contrast, is a custom-compounded preparation of FDA-licensed allergen extract that induces allergen-specific immune tolerance.
Before booking a first allergy injection, Curex's at-home IgE blood test with allergist review confirms which allergens are the actual drivers of symptoms, so the injection prescription targets the right antigens.
Each allergy injection visit at an allergist office follows a standardized six-step protocol per Cox 2011: pre-injection screening, vial verification, subcutaneous administration, 30-minute observation, skin-response measurement, and discharge with instructions for delayed reactions.
Pre-injection screening evaluates for conditions that increase systemic-reaction risk: worsening asthma, acute respiratory infection or fever, new medications (especially beta-blockers, which blunt epinephrine response if a reaction occurs, and ACE inhibitors, linked to more severe reactions in some venom patients), and (for women) pregnancy. The AAAAI/ACAAI surveillance data found that asthma screening was highly prevalent — 86% of clinics always screened before injection (Epstein TG et al., PMID 23535092).
How allergy shots retrain your immune system
A single allergy injection introduces a carefully titrated dose of allergen extract into subcutaneous tissue, where it encounters antigen-presenting cells (dendritic cells and macrophages) that process allergen peptides and present them to T lymphocytes. At the beginning of build-up, the dose is too small to trigger a clinically significant reaction but is sufficient to begin shifting the immune response. As doses escalate over successive visits, the cumulative allergen load induces allergen-specific regulatory T cells (Tregs), suppresses Th2 cytokine responses (IL-4, IL-5, IL-13), and drives IgE-to-IgG4 class-switching in B cells.
Pre-Injection Screening
Before each injection, the patient is screened for conditions that increase systemic-reaction risk: worsening asthma, acute illness, fever, new beta-blocker or ACE inhibitor medications, and pregnancy. Screening for worsening asthma was documented in 86% of surveilled clinics (Epstein 2013, PMID 23535092). Patients with FEV1 below 70% predicted should not receive their scheduled dose that day.
Vial Verification and Dose Confirmation
The vial is checked against two patient identifiers, the prescribed dose, the dilution (red = maintenance concentrate, then yellow 1:10, blue 1:100, green 1:1,000, silver 1:10,000), and the beyond-use date. This two-identifier verification step is a defense against dosing errors, which are a leading cause of severe reactions.
Subcutaneous Injection and Observation
The injection is delivered subcutaneously into the posterolateral upper outer arm, alternating arms each visit. Volume escalates from 0.05 mL (most dilute) to 0.5 mL (maintenance) over the build-up phase. The patient waits 30 minutes in-office; staff measure the local wheal/erythema before discharge. A wheal exceeding 25-35 mm may prompt dose reduction at the next visit.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youSide effects — what to watch for
The side-effect spectrum of a single allergy injection spans local reactions (expected) to systemic anaphylaxis (rare but requiring immediate intervention). The 30-minute at-home observation captures approximately 70% of serious reactions within the observation window.
Frequently asked questions
What does a single allergy injection consist of?
A single allergy injection involves: (1) pre-injection screening for contraindications including worsening asthma, fever, beta-blocker use, and pregnancy; (2) verification of the vial, prescribed dose, and dilution label; (3) subcutaneous injection of 0.05-0.5 mL of allergen extract into the posterolateral upper outer arm using a 26-27G half-inch needle; (4) a mandatory 30-minute observation; (5) a check of the local wheal/erythema at the injection site; and (6) instructions to report delayed reactions. The extract is FDA-licensed allergenic protein custom-compounded for the patient's specific sensitizations per Cox 2011 Practice Parameter.
Can one allergy injection make a difference?
A single allergy injection alone does not produce meaningful immune tolerance. SCIT requires cumulative dose escalation over 24-28 build-up visits and then years of maintenance injections to induce the Treg expansion and IgG4 blocking-antibody production that produce disease-modifying benefit. Cochrane meta-analysis (Calderón 2007, 51 RCTs / 2,871 patients) found the symptom SMD of -0.73 reflects outcomes in patients who complete a course, not isolated injections. One injection is a meaningful first step only in the context of completing the full course.
Why do you have to stay 30 minutes after each allergy injection?
The 30-minute observation after every allergy injection matters because approximately 70% of serious systemic reactions — including anaphylaxis — begin within that window (Cox 2011 Summary Statement 32). Allergy injections introduce allergen directly into the body, and a small percentage of patients experience systemic reactions that require immediate epinephrine. That is why a prescribed epinephrine auto-injector is confirmed on hand before your first injection, and why you stay put for the full 30 minutes after each dose rather than resuming activity immediately — so you can use it and call 911 if symptoms progress. With at-home SCIT, your first dose and every dose change are supervised live over Zoom by the prescribing allergist. This applies to every injection, including maintenance doses.
Is an allergy injection the same as a Kenalog shot?
No. An allergy injection in the immunotherapy sense (SCIT) contains FDA-licensed allergen extract and induces immune tolerance over a 3-5-year course. Kenalog-40 (triamcinolone acetonide) is a depot corticosteroid that suppresses inflammation for days to weeks — it contains no allergen and does not modify the underlying allergic disease. The FDA label for Kenalog includes allergic rhinitis only for cases 'intractable to adequate trials of conventional treatment,' and the AAAAI/ACAAI rhinitis practice parameter discourages routine use and contraindicates repeated injections due to HPA-axis suppression. These are different drug classes that share only the word 'injection.'
What should I avoid before and after an allergy injection?
Before an allergy injection, avoid vigorous exercise for approximately two hours (increased vascular perfusion accelerates systemic allergen absorption). Report any new medications, especially beta-blockers (which reduce epinephrine effectiveness if a reaction occurs) or ACE inhibitors (linked to more severe reactions in venom patients per Cox 2011). Do not come for an injection if you have worsening asthma symptoms, a respiratory infection, or a fever. After the injection, avoid vigorous exercise and hot baths or showers immediately post-injection, as both increase absorption rate. Report any local reactions larger than a golf ball or any symptoms outside the injection site, including hives, shortness of breath, or dizziness, before the 30-minute observation ends.
Where on the arm is the allergy injection given?
SCIT injections are given subcutaneously into the posterolateral upper outer arm over the deltoid region, alternating arms each visit per Cox 2011 Summary Statement 60. The injection goes into the subcutaneous fat — not intramuscular and not intradermal. Intramuscular injection would accelerate systemic absorption and increase the risk of systemic reactions. The deltoid region's loose subcutaneous tissue and easy visibility for monitoring local reactions make it the standard SCIT site. Arms are alternated because repeated injections into the same site may cause local tissue changes and impair absorption.
Related Articles
Cat Allergy Shot for Humans | Curex SCIT Guide
This page covers cat allergy shots FOR HUMANS — SCIT with FDA-standardized Fel d 1 extract (10,000 BAU/mL). Not Cytopoint. Not Apoquel. ~72% symptom reduction in RCTs.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Exposure Therapy: Safe vs Unsafe | Curex
Allergy exposure therapy = SCIT or SLIT: controlled escalating allergen doses under allergist care inducing tolerance. Unsupervised exposure is dangerous.
Read moreAllergy Shots for Kids: PAT Study & Age Guide | Curex
Allergy shots from age 5. PAT study: 3 yrs SCIT halves asthma risk (OR 4.6). At-home SCIT via Curex for eligible pediatric families.
Read moreNames of Allergy Shots: Complete Guide | Curex
Names of allergy shots: SCIT, AIT, hyposensitization, allergy vaccine (WHO 1998). Brands belong to SLIT tablets, biologics, and steroids — not SCIT itself.
Read moreInjection for Allergy: Which One Is Right? | Curex
Allergy injections in 4 categories: SCIT (immunotherapy), Xolair/Dupixent (biologics), Kenalog (steroids), epinephrine. Only SCIT is disease-modifying.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.